It is reported that DGCR5 expression in lung cancer patients and their sera are either upregulated (Dong et al., 2018; Wang R. et al., 2018) or downregulated (Chen et al., 2017; Luo et al., 2018). The gene discussed is DGCR5; the disease is lung carcinoma.